Covidien (NYSE:COV) will report earnings before markets open on Friday, April 26th. Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
Here is your Cheat Sheet to Covidien Earnings:
Earnings Expectations: Analysts expect earnings of $1.09 per share on revenues of $3.12 billion. Currently, the company’s P/E ratio stands at 16.91.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $1.14 to a profit $1.15. For the current year, the average estimate is a profit of $4.49, which is better than the estimate ninety days ago.
Here’s how Covidien has been performing on an annual basis:
|Revenue ($) in millions||9,910||10,260||10,430||11,570||11,850|
|Diluted EPS ($)||2.70||1.79||3.24||3.76||3.92|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||2,898||2,946||3,007||3,001||3,056|
|Diluted EPS ($)||1.02||1.02||0.93||0.95||1.03|
Covidien has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)